Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
Excellent medical, dental, and vision coverage.
O que faz você mais feliz no trabalho?
Celebrating success achieved as a team.
Quais são algumas das melhores coisas da sua equipe?
We all work hard together to meet deadlines and help patients.
O que você mais gosta nos lideres?
The leadership team is connected to everyone, not isolated in a board room.
Other Employee Reviews for Karyopharm Therapeutics
×